Evaluation of the use of PTQ™ implants for the treatment of incontinent patients due to internal anal sphincter dysfunction

Colorectal Disease

Volumn 10, Issue 1, 2008, Pages 89-94

  de la Portilla, Fernando ^a   Fernandez A ^b   Leon E ^b   Rada, R ^a   Cisneros, N ^a   Maldonado, V H ^a   Vega, J ^a   Espinosa, E ^a  

^a HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Anorectal sphincter; Faecal incontinence; Internal anal sphincter augmentation; Silicone

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; FLEET ENEMA; GENTAMICIN; METRONIDAZOLE; PARACETAMOL; BIOMATERIAL; DIMETICONE;

ADULT; AGED; ANORECTAL PRESSURE; ANTIBIOTIC PROPHYLAXIS; ANUS PRURITUS; ANUS SPHINCTER DISORDER; ARTICLE; CLINICAL ARTICLE; ENDOSCOPIC ECHOGRAPHY; FECES INCONTINENCE; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE INFECTION; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SILICONE PROSTHESIS; ANAL CANAL; DRUG EFFECT; EVALUATION; HOSPITALIZATION; INTRALESIONAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROBABILITY; PROSTHESES AND ORTHOSES; RECTOSCOPY; RISK ASSESSMENT; TREATMENT OUTCOME;

AGED; ANAL CANAL; BIOCOMPATIBLE MATERIALS; DIMETHYLPOLYSILOXANES; ENDOSONOGRAPHY; FECAL INCONTINENCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; PROBABILITY; PROCTOSCOPY; PROSTHESES AND IMPLANTS; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 36949031921     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2007.01276.x     Document Type: Article

References (24)

1. Nelson R, Norton N, Cautley E, Furner S. Community based prevalence of anal incontinence. JAMA 1995; 274: 559-61.
2. Macmillan AK, Merrie AE, Marshall RJ, Parry BR. The prevalence of faecal incontinence in community-dwelling adults: A systematic review of the literature. Dis Colon Rectum 2004; 47: 1341-9.
3. Rao SS. Pathophysiology of adult faecal incontinence. Gastroenterology 2004; 126: 14-22.
4. Altomare DF, Rinaldi M, Sallustio PL, Martino P, De Fazio M, Memeo V. Long-term effects of stapled haemorrhoidectomy on internal anal function and sensitivity. Br J Surg 2001; 88: 1487-91
5. Norton C, Kamm MA. Outcome of biofeedback for faecal incontinence. Br J Surg 1999; 86: 1159-63.
6. Leroi AM, Kamm MA, Weber J, Denis P, Hawley PR. Internal anal sphincter repair. Int J Colorectal Dis 1997; 12: 243-5.
7. Lehur PA, Roig JV, Duinslaeger M. Artificial anal sphincter: Prospective clinical and manometric evaluation. Dis Colon Rectum 2000; 43: 1100-6.
8. Matzel KE, Kamm MA, Stosser M, Baeten CG, Christiansen J, Madoff R, Mellgren A, Nicholls RJ, Rius J, Rosen H. Sacral spinal nerve stimulation for faecal incontinence: Multicentre study. Lancet 2004; 363: 1270-6.
9. Bernardi C, Favetta U, Pescatori M. Autologous fat injection for treatment of faecal incontinence: Manometric and echographic assessment. Plast Reconstr Surg 1998; 102: 1626-8.
10. Shafik A. Polytetrafluoroethylene injection for the treatment of partial faecal incontinence. Int Surg 1993; 78: 159-61.
11. Kumar D, Benson MJ, Bland JE. Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence. Br J Surg 1998; 85: 978-9.
12. Davis K, Kumar D, Poloniecki J. Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence. Aliment Pharmacol Ther 2003; 18: 237-43.
13. Harriss DR, Lacavou JW, Lemberger RJ. Per-urethral silicone microimplants (Macroplastique) for treatment of genuine stress incontinence. Br J Urol 1996; 78: 722-5.
14. Malouf AJ, Vaizey CJ, Norton CS, Kamm MA. Internal anal sphincter augmentation for faecal incontinence using injectable silicone biomaterial. Dis Colon Rectum 2001; 44: 595-600.
15. Tjandra JJ, Lim JF, Hiscock R, Rajendra P. Injectable silicone biomaterial for faecal incontinence caused by internal anal sphincter dysfunction is effective. Dis Colon Rectum 2004; 47: 2138-46.
16. Jorge JMN, Wexner SD. Etiology and management of faecal incontinence. Dis Colon Rectum 1993; 36: 77-97.
17. Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG et.al. Faecal incontinence quality of life scale. Quality of life instrument for patients with faecal incontinence. Dis Colon Rectum 2000; 43: 9-17.
18. Chan MKY, Tjandra JJ. Injectable silicone biomaterial (PTQ) to treat faecal incontinence after hemorrhoidectomy. Dis Colon Rectum 2006; 49: 433-8.
19. Vaizey CJ, Kamm MA. Injectable bulking agents for treating faecal incontinence. Br J Surg 2005; 92: 521-7.
20. Uroplasty. Product overview. [Accessed 12 July 2005]. Available from: http://www.uroplasty.com/Products.asp.
21. Nijhuis PH, van den Bogaard TE, Daemen MJ, Baeten CG. Perianal injection of polydimethylsiloxane (Bioplastique TM Implants) paste in the treatment of soiling. Dis Colon Rectum 1998; 41: 624-9.
22. Gibbons CP, Trowbridge EA, Bannister JJ, Read NW. Role of anal cushions in maintaining continence. Lancet 1986; 19: 886-8.
23. Davis KJ, Kumar D, Bland J. Results of anal injection of 'Durasphere' in patients with anal incontinence. Colorectal Dis 2001; 3 (Suppl. 1): 21[A].
24. Person B, Wexner SD. Advances in the surgical treatment of faecal incontinence. Surg Innov 2005; 12: 7-21.